(Q79905924)

English

Transcutaneous immunization by merely prolonging the duration of antigen presence on the skin of mice induces a potent antigen-specific antibody response even in the absence of an adjuvant

scientific article published on 01 November 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18023509%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Transcutaneous immunization by merely prolonging the duration of antigen presence on the skin of mice induces a potent antigen-specific antibody response even in the absence of an adjuvant (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18023509%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

immunologic adjuvant

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18023509%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Seishiro Naito

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18023509%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Jun-ichi Maeyama

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18023509%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Motohide Takahashi

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18023509%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Isao Hamaguchi

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18023509%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Kazunari Yamaguchi

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18023509%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 November 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18023509%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18023509%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18023509%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

52

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18023509%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

8762-8770

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18023509%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Skin immunization made possible by cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Immunization onto shaved skin with a bacterial enterotoxin adjuvant protects mice against respiratory syncytial virus (RSV).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Transcutaneous immunization with inactivated influenza virus induces protective immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Modulation of immune responses with transcutaneously deliverable adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Initiation of adaptive immune responses by transcutaneous immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Transcutaneous immunization: a human vaccine delivery strategy using a patch

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Cutting edge: priming of CTL by transcutaneous peptide immunization with imiquimod

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Transcutaneous immunization with tetanus toxoid and mutants of Escherichia coli heat-labile enterotoxin as adjuvants elicits strong protective antibody responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Comparison of mucosal and systemic humoral immune responses after transcutaneous and oral immunization strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Induction of cytotoxic T-lymphocytes by electroporation-enhanced needle-free skin immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Low-frequency ultrasound as a transcutaneous immunization adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Development of novel fusogenic vesosomes for transcutaneous immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

A novel transcutaneous plasmid-dimethylsulfoxide delivery technique for avian nucleic acid immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Effect of transcutaneous immunization with co-administered antigen and cholera toxin on systemic and mucosal antibody responses in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Simulated solar UVB exposure inhibits transcutaneous immunization to cholera toxin via an irradiated skin site in cattle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Effect of skin barrier disruption on immune responses to topically applied cross-reacting material, CRM(197), of diphtheria toxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Immunological activation following transcutaneous delivery of HR-gp100 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Transcutaneous immunization with Clostridium difficile toxoid A induces systemic and mucosal immune responses and toxin A-neutralizing antibodies in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Needle-free skin patch vaccination method for anthrax

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

The haemopoietic growth factor, Flt3L, alters the immune response induced by transcutaneous immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Number of cell layers of the stratum corneum in normal skin - relationship to the anatomical location on the body, age, sex and physical parameters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Induction of anti-chlamydial mucosal immunity by transcutaneous immunization is enhanced by topical application of GM-CSF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

A synthetic HIV-1 Tat protein breaches the skin barrier and elicits Tat-neutralizing antibodies and cellular immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Altered permeability and disordered cutaneous immunoregulatory function in mice with acute barrier disruption

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Principles of transcutaneous immunization using cholera toxin as an adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Ir gene control of the murine secretory IgA response to cholera toxin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholera toxin as a mucosal adjuvant: effects of H-2 major histocompatibility complex and lps genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.031

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.10.031

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18023509%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18023509%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79905924&oldid=1749493934"